Weight loss and metabolic improvement in morbidly obese subjects implanted for 1 year with an endoscopic duodenal-jejunal bypass liner

Annals of Surgery

Volumn 255, Issue 6, 2012, Pages 1080-1085

  Escalona, Alex ^a   Pimentel, Fernando ^a   Sharp, Allan ^a   Becerra, Pablo ^a   Slako, Milenko ^a   Turiel, Dannae ^a   Muñoz, Rodrigo ^a   Bambs, Claudia ^a   Guzmán, Sergio ^a   Ibáñez, Luis ^a   Gersin, Keith ^b  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^b CAROLINAS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; BLOOD PRESSURE FLUCTUATION; BODY WEIGHT; CARDIOMETABOLIC RISK; CONTROLLED STUDY; DIET RESTRICTION; DYSLIPIDEMIA; ENDOSCOPIC SURGERY; FATTY LIVER; FEMALE; FOLLOW UP; GASTROENTERITIS; GLYCEMIC CONTROL; HUMAN; HYPERTENSION; INSULIN RESISTANCE; INTESTINE SURGERY; JEJUNOILEAL BYPASS; MALE; METABOLIC SYNDROME X; MORBID OBESITY; NAUSEA; NON INSULIN DEPENDENT DIABETES MELLITUS; OPEN STUDY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; UPPER ABDOMINAL PAIN; VOMITING; WAIST CIRCUMFERENCE; WEIGHT CHANGE; WEIGHT REDUCTION;

ADULT; BARIATRIC SURGERY; DIABETES MELLITUS, TYPE 2; DUODENUM; FEMALE; HEART DISEASES; HUMANS; JEJUNUM; MALE; METABOLIC DISEASES; MIDDLE AGED; OBESITY, MORBID; PROSPECTIVE STUDIES; PROSTHESES AND IMPLANTS; PROSTHESIS IMPLANTATION; WEIGHT LOSS;

EID: 84861341171     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e31825498c4     Document Type: Article

References (30)

1. Flegal KM, Carroll MD, Ogden CL, et al. Prevalence and trends in obesity among US adults, 1999-2008. JAMA. 2010;303:235-241.
2. Eckel RH. Clinical practice. Nonsurgical management of obesity in adults. N Engl J Med. 2008;358:1941-1950.
3. Adams TD, Gress RE, Smith SC, et al. Long-termmortality after gastric bypass surgery. N Engl J Med. 2007;357:753-61.
4. Christou NV, Sampalis JS, Liberman M, et al. Surgery decreases long-term mortality, morbidity, and health care use in morbidly obese patients. Ann Surg. 2004;240:416-423; discussion 23-24.
5. Sowemimo OA, Yood SM, Courtney J, et al. Natural history of morbid obesity without surgical intervention. Surg Obes Relat Dis. 2007;3:73-77; discussion 7. (Pubitemid 46112406)
6. Sjostrom L, Narbro K, Sjostrom CD, et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med. 2007;357:741-752. (Pubitemid 47295641)
7. Buchwald H, Estok R, Fahrbach K, et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med. 2009;122:248-256.e5.
8. Flum DR, Belle SH, King WC, et al. Perioperative safety in the longitudinal assessment of bariatric surgery. N Engl J Med. 2009;361:445-454.
9. Nguyen NT, Paya M, Stevens CM, et al. The relationship between hospital volume and outcome in bariatric surgery at academic medical centers. Ann Surg. 2004;240:586-593; discussion 93-94.
10. HutterMM,Randall S, Khuri SF, et al. Laparoscopic versus open gastric bypass for morbid obesity: a multicenter, prospective, risk-adjusted analysis from the National Surgical Quality Improvement Program. Ann Surg. 2006;243:657-662; discussion 62-66. (Pubitemid 44305583)
11. Flum DR, Salem L, Elrod JA, et al. Early mortality among Medicare beneficiaries undergoing bariatric surgical procedures. JAMA. 2005;294:1903-1908. (Pubitemid 41464691)
12. Afonso BB, Rosenthal R, Li KM, et al. Perceived barriers to bariatric surgery among morbidly obese patients. Surg Obes Relat Dis. 2010;6:16-21.
13. Rodriguez-Grunert L, Galvao Neto MP, Alamo M, et al. First human experience with endoscopically delivered and retrieved duodenal-jejunal bypass sleeve. Surg Obes Relat Dis. 2008;4:55-59.
14. Rodriguez L, Reyes E, Fagalde P, et al. Pilot clinical study of an endoscopic, removable duodenal-jejunal bypass liner for the treatment of type 2 diabetes. Diabetes Technol Ther. 2009;11:725-732.
15. TarnoffM,Rodriguez L, Escalona A, et al.Open label, prospective, randomized controlled trial of an endoscopic duodenal-jejunal bypass sleeve versus low calorie diet for pre-operative weight loss in bariatric surgery. Surg Endosc. 2009;23:650-656.
16. Schouten R, Rijs CS, Bouvy ND, et al. A multicenter, randomized efficacy study of the EndoBarrier Gastrointestinal Liner for presurgical weight loss prior to bariatric surgery. Ann Surg. 2010;251:236-243.
17. Levine A, Ramos A, Escalona A, et al. Radiographic appearance of endoscopic duodenal-jejunal bypass liner for treatment of obesity and type 2 diabetes. Surg Obes Relat Dis. 2009;5:371-374.
18. Gersin KS, Keller JE, Stefanidis D, et al. Duodenal-jejunal bypass sleeve: a totally endoscopic device for the treatment of morbid obesity. Surg Innov. 2007;14:275-278.
19. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA. 2002;287:356-359. (Pubitemid 34251969)
20. Deitel M, Gawdat K, Melissas J. Reporting weight loss 2007. Obes Surg. 2007;17:565-568. (Pubitemid 46945427)
21. NIH conference. Gastrointestinal surgery for severe obesity. Consensus Development Conference Panel. Ann Intern Med. 1991;115:956-961.
22. Dixon JB, Laurie CP, Anderson ML, et al. Motivation, readiness to change, and weight loss following adjustable gastric band surgery. Obesity (Silver Spring). 2009;17:698-705.
23. Wadden TA, Berkowitz RI, Womble LG, et al. Randomized trial of lifestyle modification and pharmacotherapy for obesity. N Engl JMed. 2005;353:2111-2120. (Pubitemid 41653103)
24. Papalazarou A, Yannakoulia M, Kavouras SA, et al. Lifestyle intervention favorably affects weight loss andmaintenance following obesity surgery. Obesity (Silver Spring). 2010;18:1348-1353.
25. DiGiorgi M, Rosen DJ, Choi JJ, et al. Re-emergence of diabetes after gastric bypass in patients with mid-to long-term follow-up. Surg Obes Relat Dis. 2010;6:249-253.
26. Anderson JW, Konz EC, Frederich RC, et al. Long-term weight-loss maintenance: a meta-analysis of US studies. Am J Clin Nutr. 2001;74:579-584. (Pubitemid 33015142)
27. Kraschnewski JL, Boan J, Esposito J, et al. Long-termweight loss maintenance in the United States. Int J Obes (Lond). 2010;34:1644-1654.
28. The Diabetes Prevention Program. Design and methods for a clinical trial in the prevention of type 2 diabetes. Diabetes Care. 1999;22:623-634.
29. Knowler WC, Fowler SE, Hamman RF, et al. 10-year follow-up of diabetes incidence andweight loss in theDiabetes Prevention Program Outcomes Study. Lancet. 2009;374:1677-1686.
30. Tsai AG, Wadden TA. Systematic review: an evaluation of major commercial weight loss programs in the United States. Ann Intern Med. 2005;142: 56-66.